Manulife (Manufacturers Life Insurance)
COGT icon

Manulife (Manufacturers Life Insurance)’s Cogent Biosciences COGT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.7M Buy
121,486
+15,969
+15% +$559K ﹤0.01% 1215
2026
Q1 		$4.06M Buy
105,517
+9,506
+10% +$351K ﹤0.01% 1228
2025
Q4 		$3.46M Buy
96,011
+32,413
+51% +$911K ﹤0.01% 1328
2025
Q3 		$913K Buy
63,598
+24,683
+63% +$292K ﹤0.01% 1898
2025
Q2 		$279K Buy
38,915
+5,030
+15% +$27.9K ﹤0.01% 2416
2025
Q1 		$203K Sell
33,885
-388
-1% -$3.04K ﹤0.01% 2494
2024
Q4 		$267K Sell
34,273
-664
-2% -$6.62K ﹤0.01% 2503
2024
Q3 		$377K Sell
34,937
-815
-2% -$7.93K ﹤0.01% 2381
2024
Q2 		$301K Buy
35,752
+4,528
+15% +$34.3K ﹤0.01% 2421
2024
Q1 		$210K Sell
31,224
-8,321
-21% -$51.4K ﹤0.01% 2574
2023
Q4 		$233K Sell
39,545
-788
-2% -$6.04K ﹤0.01% 2537
2023
Q3 		$393K Buy
40,333
+13,257
+49% +$157K ﹤0.01% 2252
2023
Q2 		$321K Buy
27,076
+2,403
+10% +$27.6K ﹤0.01% 2312
2023
Q1 		$266K Hold
24,673
– – ﹤0.01% 2379
2022
Q4 		$285K Buy
24,673
+6,716
+37% +$83.2K ﹤0.01% 2340
2022
Q3 		$268K Sell
17,957
-486
-3% -$6.66K ﹤0.01% 2375
2022
Q2 		$166K Buy
18,443
+2,235
+14% +$15.3K ﹤0.01% 2738
2022
Q1 		$121K Sell
16,208
-4,060
-20% -$28.3K ﹤0.01% 2925
2021
Q4 		$174K Sell
20,268
-1,410
-7% -$12.3K ﹤0.01% 2940
2021
Q3 		$182K Sell
21,678
-1,557
-7% -$11.9K ﹤0.01% 3014
2021
Q2 		$188K Buy
+23,235
New +$196K ﹤0.01% 3138

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s COGT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Cogent Biosciences (COGT) stake by 15% in Q2 2026, buying an estimated $559K and bringing the position to 121,486 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

Manulife (Manufacturers Life Insurance) first reported a position in COGT in Q2 2021 and has held it in 21 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 121,486 shares of Cogent Biosciences worth $4.7M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 15,969 Cogent Biosciences shares in Q2 2026, an estimated $559K.
  • Cogent Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1215 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cogent Biosciences in Q2 2021 and has held it in 21 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.